Pyrimidine derivatives with antitubercular activity

被引：53

作者：

Finger, Vladimir ^{[1
,2
]}

Kufa, Martin ^{[1
,2
]}

Soukup, Ondrej ^{[2
]}

Castagnolo, Daniele ^{[3
]}

Roh, Jaroslav ^{[1
]}

Korabecny, Jan ^{[2
]}

机构：

[1] Charles Univ Prague, Fac Pharm Hradec Kralove, Akad Heyrovskeho 1203, Hradec Kralove 50005, Czech Republic

[2] Univ Hosp Hradec Kralove, Biomed Res Ctr, Sokolska 581, Hradec Kralove 50005, Kralove, Czech Republic

[3] UCL, Dept Chem, 20 Gordon St, London WC1H 0AJ, England

来源：

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | 2023年 / 246卷

关键词：

Mycobacterium tuberculosis; Pyrimidine; Tuberculosis; Drug development; Structure-activity relationships; KILL MYCOBACTERIUM-TUBERCULOSIS; THYMIDINE MONOPHOSPHATE KINASE; CYTOCHROME BC(1) COMPLEX; D-RIBOSE 2'-EPIMERASE; ANTIMYCOBACTERIAL ACTIVITY; POTENT INHIBITORS; CRYSTAL-STRUCTURE; COMBINATION THERAPY; DPRE1; INHIBITORS; DRUG DISCOVERY;

D O I：

10.1016/j.ejmech.2022.114946

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Small molecules with antitubercular activity containing the pyrimidine motif in their structure have gained more attention after three drugs, namely GSK 2556286 (GSK-286), TBA-7371 and SPR720, have entered clinical trials. This review provides an overview of recent advances in the hit-to-lead drug discovery studies of antitubercular pyrimidine-containing compounds with the aim to highlight their structural diversity. In the first part, the review discusses the pyrimidine compounds according to their targets, pinpointing the structure-activity relationships of each pyrimidine family. The second part of this review is concentrated on antitubercular pyrimidine derivatives with a yet unexplored or speculative target, dividing the compounds according to their structural types.

引用

页数：17

共 114 条

[91] Novel inhibitors of Mycobacterium tuberculosis growth based on modified pyrimidine nucleosides and their analogues [J].

Shmalenyuk, E. R. ;

Kochetkov, S. N. ;

Alexandrova, L. A. .

RUSSIAN CHEMICAL REVIEWS, 2013, 82 (09) :896-915

[92] The Complex Mechanism of Antimycobacterial Action of 5-Fluorouracil [J].

Singh, Vinayak ;

Brecik, Miroslav ;

Mukherjee, Raju ;

Evans, Joanna C. ;

Svetlikova, Zuzana ;

Blasko, Jaroslav ;

Surade, Sachin ;

Blackburn, Jonathan ;

Warner, Digby F. ;

Mikusova, Katarina ;

Mizrahi, Valerie .

CHEMISTRY & BIOLOGY, 2015, 22 (01) :63-75

[93] Structure-aided optimization of non-nucleoside M. tuberculosis thymidylate kinase inhibitors [J].

Song, Lijun ;

Merceron, Romain ;

Hulpia, Fabian ;

Lucia, Ainhoa ;

Gracia, Begona ;

Jian, Yanlin ;

Risseeuw, Martijn D. P. ;

Verstraelen, Toon ;

Cos, Paul ;

Ainsa, Jose A. ;

Boshoff, Helena, I ;

Munier-Lehmann, Helene ;

Savvides, Savvas N. ;

Van Calenbergh, Serge .

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 225

[94] Structure Guided Lead Generation toward Nonchiral &ITM&IT. &ITtuberculosis&IT Thymidylate Kinase Inhibitors [J].

Song, Lijun ;

Merceron, Romain ;

Gracia, Begona ;

Lucia Quintana, Ainhoa ;

Risseeuw, Martijn D. P. ;

Hulpia, Fabian ;

Cos, Paul ;

Ainsa, Jose A. ;

Munier-Lehmann, Helene ;

Savvides, Savvas N. ;

Van Calenbergh, Serge .

JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (07) :2753-2775

[95] Elaboration of a proprietary thymidylate kinase inhibitor motif towards anti-tuberculosis agents [J].

Song, Lijun ;

Risseeuw, Martijn D. P. ;

Froeyen, Matheus ;

Karalic, Izet ;

Goeman, Jan ;

Cappoen, Davie ;

Van der Eycken, Johan ;

Cos, Paul ;

Munier-Lehmann, Helene ;

Van Calenbergh, Serge .

BIOORGANIC & MEDICINAL CHEMISTRY, 2016, 24 (21) :5172-5182

[96]

Su YF, 2020, LANCET INFECT DIS, V20, P929, DOI [10.1016/S1473-3099(20)30124-9, 10.1016/51473-3099(20)30124-9]

[97] First-in-Human Evaluation of the Safety, Tolerability, and Pharmacokinetics of SPR720, a Novel Oral Bacterial DNA Gyrase (GyrB) Inhibitor for Mycobacterial Infections [J].

Talley, Angela K. ;

Thurston, Archie ;

Moore, Grayson ;

Gupta, Vipul K. ;

Satterfield, Myriah ;

Manyak, Erika ;

Stokes, Suzanne ;

Dane, Aaron ;

Melnick, David .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (11)

[98] UTILIZATION OF OPERATIONAL SCHEMES FOR ANALOG SYNTHESIS IN DRUG DESIGN [J].

TOPLISS, JG .

JOURNAL OF MEDICINAL CHEMISTRY, 1972, 15 (10) :1006-&

[99] Synthesis and evaluation of 5′-modified thymidines and 5-hydroxymethyl-2′-deoxyuridines as Mycobacterium tuberculosis thymidylate kinase inhibitors [J].

Toti, Kiran S. ;

Verbeke, Frederick ;

Risseeuw, Martijn D. P. ;

Frecer, Vladimir ;

Munier-Lehmann, Helene ;

Van Calenbergh, Serge .

BIOORGANIC & MEDICINAL CHEMISTRY, 2013, 21 (01) :257-268

[100] Benzothiazinones Are Suicide Inhibitors of Mycobacterial Decaprenylphosphoryl-β-D-ribofuranose 2′-Oxidase DprE1 [J].

Trefzer, Claudia ;

S'kovierova, Henrieta ;

Buroni, Silvia ;

Bobovska, Adela ;

Nenci, Simone ;

Molteni, Elisabetta ;

Pojer, Florence ;

Pasca, Maria R. ;

Makarov, Vadim ;

Cole, Stewart T. ;

Riccardi, Giovanna ;

Mikusova, Katarina ;

Johnsson, Kai .

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2012, 134 (02) :912-915

← 3 4 5 6 7 8 9 10 11 12 →